Chinese oncology player is the latest to join the North Carolina manufacturing party with 2 new plants in the offing
While Boston and the Bay Area reign supreme in terms of biotech hotspots, other hubs are having their chance in the sun amid a flurry of cash flooding the industry. North Carolina, for instance, has seen a ton of companies looking to establish a footprint in the state — and now a Shanghai-based oncology player will join the fold.
CARsgen Therapeutics will open two new sites in Raleigh-Durham, creating the company’s first manufacturing hub that will complement its clinical development site in Houston, the company said Monday.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.